BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16094403)

  • 1. Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor.
    Kucharczak JF; Simmons MJ; Duckett CS; Gélinas C
    Cell Death Differ; 2005 Sep; 12(9):1225-39. PubMed ID: 16094403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. µ-Calpain conversion of antiapoptotic Bfl-1 (BCL2A1) into a prodeath factor reveals two distinct alpha-helices inducing mitochondria-mediated apoptosis.
    Valero JG; Cornut-Thibaut A; Jugé R; Debaud AL; Giménez D; Gillet G; Bonnefoy-Bérard N; Salgado J; Salles G; Aouacheria A; Kucharczak J
    PLoS One; 2012; 7(6):e38620. PubMed ID: 22745672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist.
    Simmons MJ; Fan G; Zong WX; Degenhardt K; White E; Gélinas C
    Oncogene; 2008 Feb; 27(10):1421-8. PubMed ID: 17724464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities.
    D'Sa-Eipper C; Chinnadurai G
    Oncogene; 1998 Jun; 16(24):3105-14. PubMed ID: 9671389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells.
    Liu Z; Lu H; Jiang Z; Pastuszyn A; Hu CA
    Mol Cancer Res; 2005 Jan; 3(1):21-31. PubMed ID: 15671246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.
    Fan G; Simmons MJ; Ge S; Dutta-Simmons J; Kucharczak J; Ron Y; Weissmann D; Chen CC; Mukherjee C; White E; Gélinas C
    Blood; 2010 Apr; 115(17):3559-69. PubMed ID: 20185581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity.
    D'Sa-Eipper C; Subramanian T; Chinnadurai G
    Cancer Res; 1996 Sep; 56(17):3879-82. PubMed ID: 8752150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow.
    Choi SS; Park IC; Yun JW; Sung YC; Hong SI; Shin HS
    Oncogene; 1995 Nov; 11(9):1693-8. PubMed ID: 7478596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bfl-1S, a novel alternative splice variant of Bfl-1, localizes in the nucleus via its C-terminus and prevents cell death.
    Ko JK; Lee MJ; Cho SH; Cho JA; Lee BY; Koh JS; Lee SS; Shim YH; Kim CW
    Oncogene; 2003 Apr; 22(16):2457-65. PubMed ID: 12717423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells.
    Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B
    J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-apoptotic role of Bfl-1 in staurosporine-treated B-lymphoblastic cells.
    Shim YH; Byun EK; Lee MJ; Huh J; Kim CW
    Int J Hematol; 2000 Dec; 72(4):484-90. PubMed ID: 11197217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of Bcl-2 binding proteins that exhibit homology with BAG-1 and suppressor of death domains protein.
    Antoku K; Maser RS; Scully WJ; Delach SM; Johnson DE
    Biochem Biophys Res Commun; 2001 Sep; 286(5):1003-10. PubMed ID: 11527400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells.
    McDonnell MA; Wang D; Khan SM; Vander Heiden MG; Kelekar A
    Cell Death Differ; 2003 Sep; 10(9):1005-15. PubMed ID: 12934075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversion of Bfl-1, an anti-apoptotic Bcl-2 family protein, to a potent pro-apoptotic protein by fusion with green fluorescent protein (GFP).
    Ko JK; Choi KH; Kim HJ; Choi HY; Yeo DJ; Park SO; Yang WS; Kim YN; Kim CW
    FEBS Lett; 2003 Sep; 551(1-3):29-36. PubMed ID: 12965200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of A1/Bfl-1 expression in peripheral splenic B cells.
    Trescol-Biémont MC; Verschelde C; Cottalorda A; Bonnefoy-Bérard N
    Biochimie; 2004; 86(4-5):287-94. PubMed ID: 15194232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal region of Bfl-1 induces cell death that accompanies caspase activation when fused with GFP.
    Yang WS; Ko JK; Park SO; Choi HY; Kim YN; Kim CW
    J Cell Biochem; 2005 Apr; 94(6):1234-47. PubMed ID: 15696550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative cytotoxicity of proteasome inhibitors and tumor necrosis factor-related apoptosis-inducing ligand in chemoresistant Bcl-2-overexpressing cells.
    Nencioni A; Wille L; Dal Bello G; Boy D; Cirmena G; Wesselborg S; Belka C; Brossart P; Patrone F; Ballestrero A
    Clin Cancer Res; 2005 Jun; 11(11):4259-65. PubMed ID: 15930365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
    Mei Y; Du W; Yang Y; Wu M
    Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.